Comparative evaluation of 11 scoring functions for molecular docking, Renxiao Wang, Yipin Lu, Shaomeng Wang, Journal of medicinal chemistry, 2003[7]
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition, Proceedings of the National Academy of Sciences, 2008[8]
Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2− p53 interaction, Journal of medicinal chemistry, 2006[9]
The PDBbind database: Collection of binding affinities for protein− ligand complexes with known three-dimensional structures, Journal of medicinal chemistry, 2004[10]
Structure-based design of potent non-peptide MDM2 inhibitors, Journal of the American Chemical Society, 2005[11]
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy, Annual review of pharmacology and toxicology, 2009[12]
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells, Hui Song, Renxiao Wang, Shaomeng Wang, Jiayuh Lin, Proceedings of the National academy of Sciences of the United States of America, 2005[13]
References
^
ab"Shaomeng Wang". umich.edu. 23 December 2014. Retrieved November 27, 2017.
Comparative evaluation of 11 scoring functions for molecular docking, Renxiao Wang, Yipin Lu, Shaomeng Wang, Journal of medicinal chemistry, 2003[7]
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition, Proceedings of the National Academy of Sciences, 2008[8]
Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2− p53 interaction, Journal of medicinal chemistry, 2006[9]
The PDBbind database: Collection of binding affinities for protein− ligand complexes with known three-dimensional structures, Journal of medicinal chemistry, 2004[10]
Structure-based design of potent non-peptide MDM2 inhibitors, Journal of the American Chemical Society, 2005[11]
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy, Annual review of pharmacology and toxicology, 2009[12]
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells, Hui Song, Renxiao Wang, Shaomeng Wang, Jiayuh Lin, Proceedings of the National academy of Sciences of the United States of America, 2005[13]
References
^
ab"Shaomeng Wang". umich.edu. 23 December 2014. Retrieved November 27, 2017.